These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 18473714

  • 21. A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine.
    Goldberg RB, Roth D.
    Am J Cardiol; 1995 Jul 13; 76(2):107A-109A. PubMed ID: 7604782
    [Abstract] [Full Text] [Related]

  • 22. Effects of alcohol consumption on pharmacokinetics, efficacy, and safety of fluvastatin.
    Smit JW, Wijnne HJ, Schobben F, Sitsen A, de Bruin TW, Erkelens DW.
    Am J Cardiol; 1995 Jul 13; 76(2):89A-96A. PubMed ID: 7604808
    [Abstract] [Full Text] [Related]

  • 23. Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience.
    Jardine A, Holdaas H.
    J Clin Pharm Ther; 1999 Dec 13; 24(6):397-408. PubMed ID: 10651972
    [Abstract] [Full Text] [Related]

  • 24. A review of the lipid-related effects of fluvastatin.
    Liberopoulos EN, Daskalopoulou SS, Mikhailidis DP, Wierzbicki AS, Elisaf MS.
    Curr Med Res Opin; 2005 Feb 13; 21(2):231-44. PubMed ID: 15801994
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of hypercholesterolemia in kidney transplant recipients].
    Fritsche L, Budde K, Neumayer HH.
    Dtsch Med Wochenschr; 2003 Apr 17; 128(16):879-81. PubMed ID: 12701034
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of efficacy and safety assessment of fluvastatin in patients <65 years versus > or =65 years of age.
    Bruckert E, Verpilleux MP, Dejager S, Isaacsohn J.
    Am J Cardiol; 2005 Oct 15; 96(8):1142-8. PubMed ID: 16214453
    [Abstract] [Full Text] [Related]

  • 27. Risk factors for cardiovascular events in Japanese patients treated with fluvastatin from the long-term event monitoring (LEM) study.
    Morishita R, Itakura H, Nakaya N, Yoshida M, Odawara M, Ichihara A, Mizuno K.
    Curr Vasc Pharmacol; 2012 Mar 15; 10(2):178-86. PubMed ID: 21824105
    [Abstract] [Full Text] [Related]

  • 28. Efficacy and safety of fluvastatin in women with primary hypercholesterolaemia.
    Peters TK, Muratti EN, Mehra M.
    Drugs; 1994 Mar 15; 47 Suppl 2():64-72. PubMed ID: 7517836
    [Abstract] [Full Text] [Related]

  • 29. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003 Mar 15; 32(6):516-7. PubMed ID: 14639833
    [No Abstract] [Full Text] [Related]

  • 30. Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia.
    Li PK, Mak TW, Chan TH, Wang A, Lam CW, Lai KN.
    Transplantation; 1995 Oct 15; 60(7):652-6. PubMed ID: 7570971
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and lipid-lowering effect of fluvastatin in hypercholesterolaemic patients on maintenance haemodialysis.
    Ichimaru N, Takahara S, Moriyama T, Kondo M, Nonomura N, Tanaka T, Wang JD, Imai E, Okuyama A, Kondo Y.
    J Int Med Res; 2004 Oct 15; 32(1):45-52. PubMed ID: 14997705
    [Abstract] [Full Text] [Related]

  • 32. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia.
    Hsu I, Spinler SA, Johnson NE.
    Ann Pharmacother; 1995 Oct 15; 29(7-8):743-59. PubMed ID: 8520093
    [Abstract] [Full Text] [Related]

  • 33. Short-term efficacy and safety of extended-release fluvastatin in a large cohort of elderly patients.
    Bruckert E, Lièvre M, Giral P, Crepaldi G, Masana L, Vrolix M, Leitersdorf E, Dejager S.
    Am J Geriatr Cardiol; 2003 Oct 15; 12(4):225-31. PubMed ID: 12888702
    [Abstract] [Full Text] [Related]

  • 34. Clinical implications of the biopharmaceutical properties of fluvastatin.
    Deslypere JP.
    Am J Cardiol; 1994 May 26; 73(14):12D-17D. PubMed ID: 8198018
    [Abstract] [Full Text] [Related]

  • 35. Fluvastatin administration at bedtime versus with the evening meal: a multicenter comparison of bioavailability, safety, and efficacy.
    Dujovne CA, Davidson MH.
    Am J Med; 1994 Jun 06; 96(6A):37S-40S. PubMed ID: 8017465
    [Abstract] [Full Text] [Related]

  • 36. Efficacy and safety of fluvastatin in patients with non-insulin-dependent diabetes mellitus and hyperlipidemia.
    Knopp RH, Frohlich J, Jokubaitis LA, Dawson K, Broyles FE, Gomez-Coronado D.
    Am J Med; 1994 Jun 06; 96(6A):69S-78S. PubMed ID: 8017470
    [Abstract] [Full Text] [Related]

  • 37. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H, Hartmann A, Stenstrøm J, Dahl KJ, Borge M, Pfister P.
    Am J Cardiol; 1995 Jul 13; 76(2):102A-106A. PubMed ID: 7604781
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetics of the combination of fluvastatin and gemfibrozil.
    Spence JD, Munoz CE, Hendricks L, Latchinian L, Khouri HE.
    Am J Cardiol; 1995 Jul 13; 76(2):80A-83A. PubMed ID: 7604806
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.